Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.
Press releases published on December 5, 2025
December 5, 2025
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Indeterminate
GlobeNewswire
December 5, 2025
Sable Announces Adoption of New Equity Incentive Plan
Indeterminate
GlobeNewswire
December 5, 2025
Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q
Indeterminate
GlobeNewswire
December 5, 2025
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
Indeterminate
GlobeNewswire
December 5, 2025
Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
Indeterminate
GlobeNewswire
December 5, 2025
Children’s National Hospital welcomes First Lady Melania Trump for holiday visit
Indeterminate
GlobeNewswire
December 5, 2025
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 5, 2025
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
Indeterminate
GlobeNewswire
December 5, 2025
Quanex Building Products Declares Quarterly Dividend
Indeterminate
GlobeNewswire
December 5, 2025
Omega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2025
Indeterminate
GlobeNewswire
December 5, 2025
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
Indeterminate
GlobeNewswire
December 5, 2025
Spyre Therapeutics Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
December 5, 2025
Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation
Indeterminate
GlobeNewswire
December 5, 2025
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 5, 2025
Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025
Indeterminate
GlobeNewswire
December 5, 2025
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 5, 2025
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 5, 2025
Announcement relating to despatch of Rule 15 proposal
Indeterminate
GlobeNewswire
December 5, 2025
TWG Projects Strong Profit Growth for 2025
Indeterminate
GlobeNewswire